Document is current

Any future updates will be listed below

PDE4 inhibitor rolipram dynamically regulates the balance between D1-MSNs and D2-MSNs in the DMS to modulate abnormal “Go” behavior associated with alcohol addiction

Crossref DOI link: https://doi.org/10.1038/s41401-025-01738-w

Published Online: 2026-02-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark